Strontium ranelate: A novel concept for the treatment of osteoporosis;Strontiumranelat - Ein neues konzept zur behandlung der osteoporose

Wiener Klinische Wochenschrift

Volumn 117, Issue 21-22, 2005, Pages 728-738

  Dimai, Hans Peter ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Dual mode of action; Fracture; Osteoporosis; Ranelic acid; Strontium ranelate

Indexed keywords

CALCIUM; STRONTIUM RANELATE;

BONE DENSITY; CELL DIVISION; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FRACTURE; HUMAN; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM; VERTEBRA FRACTURE;

ANIMALS; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; CLINICAL TRIALS; FRACTURES, SPONTANEOUS; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; THIOPHENES;

EID: 29144471280     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0471-3     Document Type: Review

References (47)

1. Bowen HJM (1966) Trace elements in biochemistry. Academic Press, London
2. Rosenthal HL, Eves MM, Cochran OA (1970) Common strontium concentration of mineralized tissues from marine and sweet water animals. Comp Biochem Physiol 32: 491-450
3. Reginster JY, Deroisy R, Jupsin I (2003) Strontiumranelate: a new paradigm in the treatment of osteoporosis. Drugs Today 39: 89-101
4. Carr TF (1967) An attempt to quantitate the short-term movement of strontium in the human adult. In: Carr TF (ed) Strontium metabolism. Academic Press, London, pp 139-148
5. Likhtarev IA, Dobroskov IA, Ilyin LA, Krasnoschekova GP, Likhtareva TM, Smirnov BI, et al (1975) A study of certain characteristics of strontium metabolism in a homogenous group of human subjects. Health Phys 28: 49-60
6. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al (2004) The effects of Strontiumranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350: 459-468
7. Hendrix JZ, Alcock NW, Archibald RM (1963) Competition between Kalzium, strontium and magnesium for absorption in the isolated rat intestine. Clin Chem 9: 734-744
8. Slat B, Kostial K, Harrisson GE (1971) Reduction in absorption and retention of strontium in rats. Health Phys 21: 811-814
9. Rosenthal HL (1981) Content of stable strontium in man and animal biota. In: Skoryna SC (ed) Handbook of stable strontium. Plenum Press, New York, pp 503-514
10. Boivin G, Deloffre P, Perrat B, Panczer G, Boudeulle M, Tsouderos Y, et al (1996) Strontium distribution and interactions with the bone mineral in monkey iliac bone after strontium salt (S12911) administration. J Bone Miner Res 11: 1302-1311
11. Grynpas MD, Marie PJ (1990) Effects of low doses of strontium on bone quality and quantity in rats. Bone 11: 313-319
12. Neufeld EB, Boskey AL (1994) Strontium alters the complexed acidic phospholipid content of mineralizing tissues. Bone 15: 425-430
13. Grynpas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M, Marie PJ (1996) Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone 18: 253-259
14. Verberckmoes SC, Behets GJ, Oste L, Bervoets AR, Lamberts LV, Drakopoulos M, Somogyi A, Cool P, Dorrine W, De Broe ME, D'Haese PC (2004) Effects of strontium on the physicochemical characteristics of hydroxyapatite. Calcif Tissue Int 75: 405-415
15. Verberckmoes SC, De Broe ME, D'Haese PC (2003) Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney Int 64: 534-543
16. Schrooten I, Cabrera W, Goodman WG, Dauwe S, Lamberts LV, Marynissen R, Dorrine W, De Broe ME, D'Haese PC (1998) Strontium causes osteomalacia in chronic renal failure rats. Kidney Int 54: 448-456
17. De Broe ME, D'Haese PC (2003) Strontium and osteomalacia in renal failure patients. Nephrol Dial Transplant 18: 215-216
18. Ozgur S, Sumer H, Kocoglu G (1996) Rickets and soil strontium. Arch Dis Child 75: 524-526
19. Farley D, Boivin G, Panczer G, Lalande A, Meunier PJ (2005) Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralisation of bone. J Bone Miner Res (WebFirst)
20. Johnson AR, Armstrong WD, Singer L (1968) The incorporation and removal of large amounts of strontium by physiologic mechanisms in mineralized tissues. Calcif Tissue Res 2: 242-252
21. Dahl SG, Allain P, Marie PJ, Mauras Y, Boivin G, Ammann P, et al (2001) Incorporation and distribution of strontium in bone. Bone 28: 446-453
22. Su Y, Bonnet J, Deloffre P, Tsouderos Y, Baron R (1992) The strontium salt S12911 inhibits bone resorption in mouse calvaria and isolated rat osteoclast cultures. Bone Miner 17 [Suppl 1]: 188
23. Takahashi N, Sasaki T, Tsouderos Y, Suda T (2003) S 12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18: 1082-1087
24. Baron R, Tsouderos Y (2002) In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450: 11-17
25. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18: 517-523
26. Dimai HP, Pietschmann P, Resch H, Leb G, Klaushofer K (2002) Guidelines for drug therapy of postmenopausal osteoporosis. Wien Med Wochenschr 152: 596-612
27. Riggs BL, Parfitt AM (2005) Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20: 177-184
28. Delannoy P, Bazot D, Marie PJ (2002) Long-term treatment with Strontiumranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 51: 906-911
29. Arlot ME, Roux JP, Boivin G (1995) Effects of strontium salt (S12911) on both tibial metaphysis and epiphysis in normal growing rats. J Bone Miner Res 10: 356
30. Amman P, Rizzoli R, Deloffre P, Tsouderos Y, Meyer JM, Bonjour JP (1995) Long-term administration of a high dose of the strontium salt S12911 has no toxic effect on bone biomechanics in female rats and may improve bone strength of the midshaft humerus. J Bone Miner Res 10: 358
31. Amman P, Rizzoli R, Deloffre P, Tsouderos Y, Meyer JM, Bonjour JP (1996) The increase in vertebral bone mass induced in intact rats by long-term administration of the strontium salt S12911 is directly correlated with vertebral bone strength. Osteoporios Int 6 (S1): 259
32. Amman P, Robin B, Bonjour JP, Tupinon-Mathieu I, Meyer JM, Rizzoli R (2001) Long-term exposure to strontiumranelate dose-dependently increases bone strength in intact female rats. Bone 28 [Suppl]: S220
33. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A (2001) Strontiumranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fasciclularis). Bone 29: 176-179
34. Morohashi T, Sano T, Harai K, Yamada S (1995) Effects of strontium on calcium metabiolism in rats II. Strontium prevents the increased rate of bone turnover in ovariectomized rats. Jpn J Pharmacol 68: 153-159
35. Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, et al (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8: 607-615
36. Marie PJ, Hott M, Modrowski D (1995) S12911, a new agent containing strontium, inhibits bone loss due to immobilization in rats. J Bone Miner Res 10 (S 1): 105
37. Raisz LG (2003) The hunting of the snark: the elusive calcium receptor(s). J Clin Invest 111: 945-947
38. Tu Q, Pi M, Karsenty G, Simpson L, Liu S, Quarles LD (2003) Rescue of the skeletal phenotype in CASR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 111: 1029-1037
39. Pi M, Garner SC, Flannery P, Spurney RF, Quarles LD (2000) Sensing of extracellular cations in CASR-deficient osteoblasts. Evidence for a novel cation-sensing mechanism. J Biol Chem 275: 3256-3263
40. Pi M, Quarles LD (2004) A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. I Bone Miner Res 19: 862-869
41. Blake GM, Fogelman I (2002) Dual energy X-ray absorptiometry and its clinical applications. Semin Musculoskelet Radiol 6: 207-217
42. Reginster JY, Seeman E, DE Vernejoul MC, Adami S, Compston J, Phenekos C, et al (2005) Strontiumranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: TROPOS Study. J Clin Endocrinol Metab 90: 2816-2822
43. Shorr E, Carter AC (1952) The usefulness of strontium as an adjuvant to calcium in the remineralization of the skeleton in man. Bull Hosp Joint Dis 13: 59-66
44. McCaslin FE Jr, Janes JM (1959) The effect of strontium lactate in the treatment of osteoporosis. Proc Staff Meetings Mayo Clin 34: 329-334
45. Skoryna SC (1981) Effects of oral supplementation with stable strontium. Can Med Assoc J 125: 703-712
46. Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, et al (2002) Strontiumranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87: 2060-2066
47. Meunier PJ, Reginster JY (2003) Design and methodology of the phase 3 trials for the clinical development of Strontiumranelate in the treatment of women with postmenopausal osteoporosis. Osteoporos Int 14 [Suppl 3]: S66-76